• By Heather Fecteau, MS, CGC
  • Posted May 1, 2024

Putting Patients First: The Ambry CARE Program®'s Commitment to Patient Experience

With 25 years of innovation experience, Ambry has been a leading pioneer in genetic testing. But Ambry prioritizes more than performing testing. Since the launch of the Ambry CARE Program® in 2019, Ambry has also consistently helped to improve the delivery of genetic services. Why CARE? We know significant gaps exist between medical guidelines…


  • By Sarah Campian, MS, CGC
  • Posted March 20, 2024

Empowering Patient-Centric Breast Care: How The Ambry CARE Program™ Provides Evolving, Personalized Risk Assessment

How would you respond if a patient asked, "What is my risk of getting breast cancer"? We may initially reference the national average: 1 in 8 (or about 13% of) people assigned female at birth (AFAB) develop breast cancer.1 However, we live in an age of personalized medicine; this statistic cannot be applied universally to every patient. Further,…


  • By Carrie Horton, MS, CGC
  • Posted February 23, 2024

Variant Interpretation in Real Time: Sometimes it Takes a Village

Every individual's genetic makeup is unique, containing the blueprint for their health, including susceptibility to diseases and potential response to treatments. But understanding your genes is like deciphering a complex code. DNA varies slightly from person to person, and interpreting the medical significance of those differences, or variants,…


  • By Liese Vito, MD
  • Posted February 7, 2024

CARE Patient Examples at Lake Health

Many patients are anxious about their family history—more than providers realize. In some cases, they may feel like a ticking time bomb with no options. In Part One of this blog series, I talked about The Ambry CARE ProgramTM and how Lake Health has been able to use it to identify more high-risk patients, increase family history and cancer risk…


  • By Liese Vito, MD
  • Posted January 24, 2024

Hereditary Cancer Testing with CARE

According to studies, 93% of high-risk women who qualify for breast MRI have not had one.1 97% of women at risk for hereditary breast/ovarian cancer have not had genetic testing.2 These healthcare gaps mean high-risk patients are being missed when it comes to proactive and preventative care. As a practicing OB-GYN for twenty years, I have seen…


  • By Kristina O'Quinn
  • Posted October 25, 2023

Off My Chest: How Negative Genetic Testing and a Supportive Community Helped Me Navigate Breast Cancer

In the fall of 2021, my eighteen-year-old child was making an appointment for an annual check-up, then handed me the phone and said, “Mom, don’t you need a check-up? Didn’t you miss your appointment last year because of COVID?” I had, in fact, missed my annual check-up and mammogram. A few days later, after the check-up and mammogram, I…


  • By Jessica Grzybowski, MS, CGC
  • Posted October 17, 2023

Understanding Gene-Disease Validity in Breast Cancer: The Power of Evidence

When it comes to understanding the genetic basis of diseases, evidence plays a crucial role. Gene-disease validity measures the strength of evidence associating pathogenic variants or changes in a gene to a genetic disease or syndrome. In the context of breast cancer, which affects approximately 1 in every 8 women, grasping gene-disease validity…


  • By Meagan Farmer
  • Posted August 9, 2023

Her Healthcare: Leveraging the CARE Program to Scale High-Risk Patient Identification

We recently met with Texas OB/GYN, Dr. Noel Boyd. We learned about her passion for caring for the whole patient and helping to identify those at increased risk for cancer so that they can make proactive choices to address their risk. Dr. Boyd’s practice implemented The CARE ProgramTM, which stands for “Comprehensive Assessment of Risk and…


  • By Meagan Farmer
  • Posted August 2, 2023

Her Healthcare: Offering Comprehensive Care with Hereditary Cancer Testing

Dr. Noel Boyd is an OB/GYN who has been in private practice in a suburb of Houston, TX, for 21 years. The patients seen in her practice, Her Healthcare, range in age from 9 to 99, and she cares for them through everything from routine exams to high-risk pregnancy, from contraception counseling to cancer screening. “I really love taking care…


  • By Jodi Tahsler
  • Posted June 13, 2023

Outlier: Runi Limary Let Her Voice Be Heard on BRCA Gene Patents

When it comes to breast cancer, Runi Limary has more personal experience than average. She not only spent time working at a nonprofit for people with breast cancer, but she was diagnosed herself at the young age of twenty-eight. When ACLU lawyers reached out to her about the court case regarding BRCA1 and BRCA2 patents to see…